Mylan Technologies Completes Expansion Of Its St. Albans, Vermont, Production Facility
09/04/2013
Through Mylan's investment, including funding for expanded research and development capabilities and additional manufacturing and laboratory space, the company is in the process of adding more than 160 new positions to its St. Albans-based workforce.
MTI produces transdermal drug delivery systems, patches that provide medication through the skin and related technologies. Since becoming a part of the Mylan manufacturing network more than 20 years ago, MTI has developed a number of branded and generic transdermal products available to patients in markets around the world, including the U.S., Canada, Europe, Japan, New Zealand and Australia.
Mylan CEO Heather Bresch said: "Mylan's investment in the ongoing growth of our transdermal franchise demonstrates our continued commitment to and confidence in our ability to provide complex generic and interchangeable products and innovative delivery alternatives, such as transdermals. Through this expansion, MTI will continue to play a critical role in the expansion and diversification of Mylan's global product portfolio, especially when it comes to difficult-to-develop and –manufacture products. I would like to thank Governor Shumlin as well as the city of St. Albans for their ongoing support of this project. Importantly, I would also like to recognize Mylan's more than 590 employees in Vermont for their hard work and dedication to our continued success."
Project Announcements
Ferrero Expands Brantford, Ontario, Canada, Production Operations
04/19/2025
Switzerland-Based ABB Expands Senatobia, Mississippi, Production Operations
04/19/2025
Wow Bao Plans Forest City, North Carolina, Manufacturing Operations
04/19/2025
B-K Tool & Design Expands Putnam County, Ohio, Manufacturing Operations
04/19/2025
Lucid Group Plans Phoenix-Coolidge, Arizona, Manufacturing Operations
04/19/2025
Coast Expands Expands Salt Lake County, Utah, Operations
04/15/2025
Most Read
-
Run a Job Task Analysis
Q4 2024
-
The Location Economics of Advanced Nuclear
Q1 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
NEW NIMBYism: A Threat to The U.S. Economy
Q4 2024
-
Power, Policy, and Site Selection in 2025
Q1 2025
-
Designing Beyond the Assembly Line
Q1 2025
-
Why Workforce Readiness Can’t Wait
Q1 2025